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Abstract
Introduction: Mycotic aneurysms account for a small proportion of all aneurysms. Escherichia coli a
gram-negative organism, is recognised as a rare cause of aortic aneurysm. We report two cases of
mycotic aneurysm caused by the same strain of multi-resistant Escherichia coli. The purpose of this
case report is to highlight the possibility that this strain may be associated with an increased risk of
endovascular infection especially in extra-aortic sites. These aneurysms can be difficult to detect and
can have serious consequences.
Case presentation: In case one, the patient presented with symptoms and signs of septicaemia
secondary to a urinary tract infection. Despite adequate treatment the patient continued with pyrexia
and raised inflammatory markers, therefore a series of CT scans of the abdomen and thorax were
performed, which revealed two intra-thoracic pseudo-aneurysms with associated haematomas. In
case two, the patient also developed Escherichia coli septicaemia. On day 44 he developed a swelling
on the right side of his neck. An ultrasound scan showed a pseudoaneurysm of the right common
carotid artery.
Conclusions: Whilst a case report cannot prove that a heightened risk exists, we suggest that it is
an area worthy of further surveillance. We recommend when older patients with atheromatosis
develop prolonged Escherichia coli septicaemia, the possibility of an infected aneurysm should be
borne in mind.
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Introduction
Bloodstream infections with Escherichia coli (E. coli) in
adults are most often related to underlying infection of the
urinary or bilary tract or other intra-abdominal focal
infections such as pericolic abscess. Metastatic blood
borne infections with E. coli that have been reported are
discitis, vertebral osteomyelitis and joint space infection
[1,2]. However, endocarditis and other endovascular
infections are rare [3,4].
Since 2003, strains of E. coli producing extended spectrum
b-lactamases (ESBLs), particularly CTX-M-15, have
become increasingly common [5]. ESBLs confer resistance
to third- and subsequent- generation cephalosporins.
Subsequently, producer strains are often also resistant to
fluoroquinolones and trimethoprim. The population of E.
coli with CTX-M enzymes in the UK is partly clonal and
one strain, “A”, is particularly widespread, being dominant
in some areas. Isolates of strain A that also possess an
acquired AmpC b-lactamase have recently been reported,
predominantly from the North-West of England [6]. The
AmpC enzyme enhances resistance to cefoxitin and to b-
lactamase inhibitor combinations, further reducing the
available treatment options.
We recently encountered two unconnected cases of
mycotic aneurysm caused by isolates of this multi-resistant
E. coli strain; both produced the CTX-M and Amp C
b-lactamase. The purpose of this report is to alert clinicians
to the possibility that this strain may be associated with an
increased risk of endovascular infection, particularly in




A 69-year-old man was admitted in August 2005,
following a six hour history of suprapubic pain, fever
and rigors. He had a long term catheter for a prostate
problem and his past history included a myocardial
infarction in 2001, followed by a series of small strokes.
As a result of these, he had a mild residual left hemiparesis
and had received a stent to his right carotid artery. On
examination he was pyrexial (39.2°C) with otherwise
normal vital signs and no new findings. Investigations
showed a low white cell count (2.5 × 109/litre) and raised
inflammatory markers, with an ESR of 84 mm/hr and C-
reactive protein of 176 mg/l. Chest X- ray revealed no
abnormalities of clinical significance.
Cultures of blood and urine grew E. coli resistant to all
cephalosporins and fluoroquinolones but susceptible to
meropenem. A diagnosis of septicaemia originating from a
urinary tract infection was made. Intravenous meropenem
1 gm three times a day was commenced. However the
patient continued to have raised inflammatory markers
with intermittent pyrexia and meropenem was stopped
after 14 days. Three sets of blood cultures taken 7 days later
all grew E. coli with the same antibiogram as found
previously. Meropenem was recommenced at the same
dose.
A computed tomography (CT) scan was requested to
explore the possibility of lymphoma or a deep abscess.
This showed a small abdominal aortic aneurysm and a
mild dilatation of the left subclavian artery (Figure 1). A
further scan was performed 2 weeks later to exclude
leakage from the abdominal aneurysm. Whilst this
possibility was discounted, two new intra-thoracic
pseudo-aneurysms and associated haematomas were
found; one was arising at the anterior aspect of the origin
of the left subclavian artery and the second in the
descending thoracic aorta (Figure 2).
The patient was transferred to a cardiothoracic surgery
centre but intervention was not advised due to his vascular
co-morbidities. Instead he was returned to our care for
conservative management and continuation of his anti-
biotics. His fever and inflammatory markers gradually
settled to normal. A third scan (Figure 3) was performed
after 4 weeks of consistent control over the infection. The
rationale was to seek any resolution of the mycotic
aneurysm as a prelude to withdrawing antibiotics. As can
be seen from these final images, considerable resolution of
the pseudo-aneurysms and haematomas had occurred.
After a further check that blood cultures and inflammatory
markers had normalised, intravenous meropenem was
Figure 1.
First scan showing only mild dilation of left subclavian artery.
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stopped after a total of 16 weeks. No further pyrexia
occurred, and the patient remained well 3 months later.
Case 2
An 80-year-old man was admitted in November 2004 with
a 3-day history of malaise, anorexia and reduced mobility.
His past history included three strokes affecting his left
side. He also had a long term urinary catheter for prostatic
disease. A routine catheter specimen of urine (CSU) taken
three weeks prior to admission grew mixed coliform
bacteria susceptible to several agents. This was not
considered to be clinically significant.
On admission his vital signs were initially satisfactory and
physical examination did not reveal any new abnormality.
A chest X-ray showed bilateral hilar lymphadenopathy,
with no clear cause. On the second day after admission, he
developed transient pyrexia of 38ºC. A CSU again grew
coliform susceptible only to mecillinam, meropenem and
gentamicin. No treatment was given.
On the 19th day pyrexia (38.1ºC) recurred and oral
trimethoprim 200 mg twice a day was commenced for
presumed urinary infection. This was changed to intrave-
nous gentamicin 300 mg once a day after blood cultures
yielded E. coli, susceptible only to gentamicin and
meropenem. Gentamicin was stopped after a week but
pyrexia recurred the following day. A diagnosis of chest
infection was made and further blood cultures were taken.
E. coli with a similar resistance profile was isolated and the
patient was commenced on intravenous meropenem
500mg, three times daily.
At day 44, he developed a swelling on the right side of his
neck. An ultrasound scan showed this to be a pseudoa-
neurysm of the right common carotid artery. Meropenem
was increased to 1g, three times daily and gentamicin was
added. In spite of apparently responding to this regimen,
with the CRP falling from 203 to 23 mg/l, the patient died
on day 69 after contracting aspiration pneumonia.
Microbiological typing
The isolates from both cases were sent to the reference
laboratory for molecular typing and characterisation of
their b-lactamases. Both belonged to UK epidemic E. coli
strain A, which produces CTX-M-15 ESBL [5]. They also
produced a CIT-type acquired CMY-23 AmpC b-lactamase.
Multi Locus Sequence Typing (MLST) showed that these
two isolates belonged to a genetic lineage ST 131, which
has been identified as an important uro-pathogenic strain
often with multiple antibiotic resistances (personal com-
munication S.Lau).
Discussion
Mycotic aneurysms (also known as infected or pseudoa-
neurysms) account for only 2.5% of all aneurysms and
1.8% of all thoracoabdominal aortic aneurysms [7,8].
Early diagnosis is important since, without medical and
often surgical management, catastrophic haemorrhage or
uncontrolled sepsis may occur. With the decline in
bacterial endocarditis, most infected aneurysms now
tend to affect the aorta and the more proximal arteries.
The spectrum of causative bacteria has shifted from gram-
Figure 2.
Second scan showing new mycotic aneurysms and
thrombus**.
Figure 3.
Third scan (recuperative phase) showing reduced size of left
subclavian artery aneurysm and clearing of thrombus.
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positive to gram-negative and in one series, these latter
accounted for 45% of all infected thoracoabdominal aortic
aneurysms, with E. coli being second in importance only to
Salmonella [9].
Increasing attention has been drawn to the link between
urological processes and infected aneurysms, arising by
dissemination of organisms originating from urinary tract
infections with overspill to the blood, facilitated by
instrumentation and indwelling catheters [10,11,12].
One study reports increasing age and atherosclerotic
problems as risk factors [10].
Our cases featuring older atheromatous patients with
urinary infection, thus far conformed to these general
patterns. The new issues that we wish to underline are that
multi-resistant E. coli have not previously been mentioned
specifically in the context of infected aneurysms. Further,
in both our cases, the same clone of E. coli was involved
and the patients shared the somewhat unusual feature of
developing non-aortic infected aneurysms (case 1, sub-
clavian artery; case 2, internal carotid). We therefore
speculate that either as a result of the prolonged
septicaemia or a specific difference in pathogenesis, non-
aortic aneurysms are more likely in this situation.
Finally, there is a recognised association between multi-
resistance and virulence in other Enterobacteriaceae such
as Salmonella typhimurium DT104. A similar linkage may
operate with the clones (for example, strain A) of this
multi resistant E. coli lineage ST131 now spreading in the
UK.
Conclusion
Whilst a case report cannot prove that a heightened risk
exists, we suggest that it is an area worthy of further
surveillance. We recommend when older patients with
atheromatosis develop prolonged E. coli septicaemia, the
possibility of infected aneurysm should be borne in mind.
Since surgery may be precluded by co-morbidities, prompt
diagnosis and prolonged antibiotic therapy is crucial.
Abbreviations
E.coli, Escherichia coli; ESBLs, extended spectrum
b-lactamases;
Consent
Written informed consent was obtained from the patient
in case one for publication of this case report. We were
unable to contact any family members of the patient
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